A 5-fluorouracil–kaempferol drug–drug cocrystal: a ternary phase diagram, characterization and property evaluation
- 17 October 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 22 (46) , 8127-8135
Abstract
A drug–drug cocrystal of 5-fluorouracil and kaempferol was comprehensively investigated and exhibits optimized solubility behavior in comparison with individual APIs.Keywords
Funding Information
- National Natural Science Foundation of China (21571194)
This publication has 37 references indexed in Scilit:
- The role of co-crystals in pharmaceutical designTrends in Pharmacological Sciences, 2013
- Polymorphs, Salts, and Cocrystals: What’s in a Name?Crystal Growth & Design, 2012
- Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in ratsBiopharmaceutics & Drug Disposition, 2009
- Combination chemotherapy of oxaliplatin and 5‐fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: A potential treatment strategyCancer Science, 2009
- Ginkgo biloba Extract Kaempferol Inhibits Cell Proliferation and Induces Apoptosis in Pancreatic Cancer CellsJournal of Surgical Research, 2008
- Efficacy and Safety of an Irinotecan plus Bolus 5-Fluorouracil and L-Leucovorin Regimen for Metastatic Colorectal Cancer in Japanese Patients: Experience in a Single Institution in JapanJapanese Journal of Clinical Oncology, 2007
- Physical stability enhancement of theophylline via cocrystallizationInternational Journal of Pharmaceutics, 2006
- Total body topical 5-fluorouracil for extensive non-melanoma skin cancerInternational Journal of Clinical Pharmacy, 2006
- Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cellsCarcinogenesis, 2004
- Infusional 5-fluorouracil in breast cancerCancer Treatment Reviews, 1994